Halozyme Therapeutics, Inc.

BROWN ADVISORY INC HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

35,870

Value ($000)

2,414

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	2,414	0.0%	35,870	12/31/2025
2025 Q3	11/14/2025	2,564	0.0%	34,965	9/30/2025
2025 Q2	8/13/2025	1,824	0.0%	35,057	6/30/2025
2025 Q1	4/30/2025	2,223	0.0%	34,833	3/31/2025
2024 Q4	2/14/2025	1,906	0.0%	39,865	12/31/2024
2024 Q3	11/13/2024	1,194	0.0%	20,863	9/30/2024
2024 Q2	8/14/2024	1,091	0.0%	20,844	6/30/2024
2024 Q1	4/24/2024	848	0.0%	20,844	3/31/2024
2023 Q4	2/8/2024	775	0.0%	20,960	12/31/2023
2023 Q3	10/25/2023	795	0.0%	20,811	9/30/2023
2023 Q2	7/31/2023	751	0.0%	20,811	6/30/2023
2023 Q1	5/8/2023	795	0.0%	20,811	3/31/2023
2022 Q4	2/13/2023	2,356	0.0%	41,413	12/31/2022
2022 Q3	11/14/2022	1,637	0.0%	41,413	9/30/2022
2022 Q2	11/14/2022	1,822	0.0%	41,413	6/30/2022
2022 Q1	11/14/2022	1,652	0.0%	41,413	3/31/2022
2021 Q4	1/27/2022	1,670	0.0%	41,534	12/31/2021
2021 Q3	11/12/2021	1,685	0.0%	41,432	9/30/2021
2021 Q2	7/29/2021	1,881	0.0%	41,413	6/30/2021
2021 Q1	5/14/2021	2,602	0.0%	62,403	3/31/2021
2020 Q4	2/12/2021	2,667	0.0%	62,440	12/31/2020
2020 Q3	11/16/2020	1,638	0.0%	62,332	9/30/2020
2020 Q2	8/14/2020	966	0.0%	36,030	6/30/2020
2020 Q1	5/15/2020	648	0.0%	36,030	3/31/2020
2019 Q4	2/14/2020	639	0.0%	36,030	12/31/2019